Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Nicholas J. Maragakis, Mamede de Carvalho & Michael D. Weiss. (2023)
Therapeutic targeting of
ALS
pathways: Refocusing an incomplete picture
. Annals of Clinical and Translational Neurology 10:11, pages 1948-1971.
Crossref
Crossref
Rebecca Bornstein, Michael T. Mulholland, Margaret Sedensky, Phil Morgan & Simon C. Johnson. (2023) Glutamine metabolism in diseases associated with mitochondrial dysfunction. Molecular and Cellular Neuroscience 126, pages 103887.
Crossref
Crossref
Marat A. Mukhamedyarov, Aydar N. Khabibrakhmanov, Venera F. Khuzakhmetova, Arthur R. Giniatullin, Guzalia F. Zakirjanova, Nikita V. Zhilyakov, Kamilla A. Mukhutdinova, Dmitry V. Samigullin, Pavel N. Grigoryev, Andrey V. Zakharov, Andrey L. Zefirov & Alexey M. Petrov. (2023) Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice. International Journal of Molecular Sciences 24:10, pages 9022.
Crossref
Crossref
Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge & Toyofumi Suzuki. (2022) Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 14:12, pages 2590.
Crossref
Crossref
Leenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, Mahmood Ali Saleh, Joy Kahn, Salome Azoulay-Ginsburg, Ayelet Rothstein, Simon Ebbinghaus, Arie Gruzman & Adrian Israelson. (2022) 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice. International Journal of Molecular Sciences 23:16, pages 9403.
Crossref
Crossref
Barış Genç, Mukesh Gautam, Benjamin R. Helmold, Nuran Koçak, Aksu Günay, Gashaw M. Goshu, Richard B. Silverman & P. Hande Ozdinler. (2022) NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone. Scientific Reports 12:1.
Crossref
Crossref
Caterina Peggion, Valeria Scalcon, Maria Lina Massimino, Kelly Nies, Raffaele Lopreiato, Maria Pia Rigobello & Alessandro Bertoli. (2022) SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants 11:4, pages 614.
Crossref
Crossref
Mudan Cai & Eun Jin Yang. (2022) Combined Treatment with Bojungikgi-Tang and Riluzole Regulates Muscle Metabolism and Dysfunction in the hSOD1G93A Mouse Model. Antioxidants 11:3, pages 579.
Crossref
Crossref
Zeynep I. Gunes, Vanessa W. Y. Kan, Shenyi Jiang, Evgeny Logunov, XiaoQian Ye & Sabine Liebscher. (2022) Cortical Hyperexcitability in the Driver’s Seat in ALS. Clinical and Translational Neuroscience 6:1, pages 5.
Crossref
Crossref
Carolyn Tallon, Anjali Sharma, Zhi Zhang, Ajit G. Thomas, Justin Ng, Xiaolei Zhu, Amanda Donoghue, Michael Schulte, Tawnjerae R. Joe, Siva P. Kambhampati, Rishi Sharma, Kevin Liaw, Sujatha Kannan, Rangaramanujam M. Kannan & Barbara S. Slusher. (2022) Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 19:1, pages 274-288.
Crossref
Crossref
Georgios Pampalakis, Georgios Angelis, Eleni Zingkou, Kostas Vekrellis & Georgia Sotiropoulou. (2022) A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis. Clinical and Translational Medicine 12:1.
Crossref
Crossref
Hsiao-Chien Ting, Hui-I Yang, Horng-Jyh Harn, Ing-Ming Chiu, Hong-Lin Su, Xiang Li, Mei-Fang Chen, Tsung-Jung Ho, Ching-Ann Liu, Yung-Jen Tsai, Tzyy-Wen Chiou, Shinn-Zong Lin & Chia-Yu Chang. (2021) Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons. Cells 10:10, pages 2773.
Crossref
Crossref
Eun Jin Yang. (2021) A Novel Supplement Attenuates Oxidative Stress-Induced TDP-43-Related Pathogenesis in TDP-43-Expressed Cells. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-9.
Crossref
Crossref
Amanda L. Wright, Paul A. Della Gatta, Sheng Le, Britt A. Berning, Prachi Mehta, Kelly R. Jacobs, Hossai Gul, Rebecca San Gil, Thomas J. Hedl, Winonah R. Riddell, Owen Watson, Sean S. Keating, Juliana Venturato, Roger S. Chung, Julie D. Atkin, Albert Lee, Bingyang Shi, Catherine A. Blizzard, Marco Morsch & Adam K. Walker. (2021) Riluzole does not ameliorate disease caused by cytoplasmic TDP‐43 in a mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience 54:6, pages 6237-6255.
Crossref
Crossref
Kirill Chaprov, Alexander Rezvykh, Sergei Funikov, Tamara A. Ivanova, Ekaterina A. Lysikova, Alexei V. Deykin, Michail S. Kukharsky, Alexey Yu. Aksinenko, Sergey O. Bachurin, Natalia Ninkina & Vladimir L. Buchman. (2021) A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice. CNS Neuroscience & Therapeutics 27:7, pages 765-775.
Crossref
Crossref
Robert A. Déziel, Amber L. Marriott, Denis G. Kay & Daphne A. Gill. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
143
160
.
Audrey Labarre & Alex Parker. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
81
103
.
Emanuele Buratti. (2020) Targeting TDP‐43 proteinopathy with drugs and drug‐like small molecules. British Journal of Pharmacology 178:6, pages 1298-1315.
Crossref
Crossref
Alizée Arnoux & Luc Dupuis. 2021. 5-HT2B Receptors. 5-HT2B Receptors
367
386
.
Lydie Boussicault, Julien Laffaire, Peter Schmitt, Philippe Rinaudo, Noëlle Callizot, Serguei Nabirotchkin, Rodolphe Hajj & Daniel Cohen. (2020) Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis. Journal of Neuroscience Research 98:12, pages 2435-2450.
Crossref
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Crossref
Si Chen, Qiao Liao, Ke Lu, Jinxia Zhou, Cao Huang & Fangfang Bi. (2020) Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis. Current Neurovascular Research 17:3, pages 275-285.
Crossref
Crossref
Marion C Hogg, Megan Rayner, Sergej Susdalzew, Naser Monsefi, Martin Crivello, Ina Woods, Alexa Resler, Lisle Blackbourn, Paola Fabbrizio, Maria Chiara Trolese, Giovanni Nardo, Caterina Bendotti, Leonard H van den Berg, Michael A van Es & Jochen H M Prehn. (2020) 5′ValCAC tRNA fragment generated as part of a protective angiogenin response provides prognostic value in amyotrophic lateral sclerosis. Brain Communications 2:2.
Crossref
Crossref
Yasuo Uchida, Yuta Yagi, Masaki Takao, Mitsutoshi Tano, Mina Umetsu, Satoshi Hirano, Takuya Usui, Masanori Tachikawa & Tetsuya Terasaki. (2020) Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood–Brain Barriers at Different Cerebral Regions and the Blood–Spinal Cord Barrier in Humans and Rats. Molecular Pharmaceutics 17:6, pages 2006-2020.
Crossref
Crossref
Jacqueline M. Ogier, Bryony A. Nayagam & Paul J. Lockhart. (2020) ASK1 inhibition: a therapeutic strategy with multi-system benefits. Journal of Molecular Medicine 98:3, pages 335-348.
Crossref
Crossref
Gessica Sala, Alessandro Arosio, Elisa Conti, Simone Beretta, Christian Lunetta, Nilo Riva, Carlo Ferrarese & Lucio Tremolizzo. (2019) Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes. Clinical Psychopharmacology and Neuroscience 17:3, pages 438-442.
Crossref
Crossref
Stavroula Tsitkanou, Paul Della Gatta, Victoria Foletta & Aaron Russell. (2019) The Role of Exercise as a Non-pharmacological Therapeutic Approach for Amyotrophic Lateral Sclerosis: Beneficial or Detrimental?. Frontiers in Neurology 10.
Crossref
Crossref
Martin Crivello, Marion C. Hogg, Elisabeth Jirström, Luise Halang, Ina Woods, Megan Rayner, Karen S. Coughlan, Sebastian L. Lewandowski & Jochen H. M. Prehn. (2019) Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model. Disease Models & Mechanisms.
Crossref
Crossref